Tapewire

Nasdaq · USD

CPIX

CUMBERLAND PHARMACEUTICALS INC

Export transactions ↓
Tapewire entity
6757
SEC CIK
0001087294
Parsed reports
362

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 24, 2023 Filed Mar 27, 2023 21:31 UTC GrantCommon Stock 5,000 $1.97 $9,850.00
Disclosure

SEC source: 0001209191-23-021262 · doc4.xml · nonDerivative · entry 1

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 209,955

F1 · shares: Restricted stock award will vest 100% on March 24, 2024.

Read SEC document
March 18, 2023 Filed Mar 21, 2023 21:27 UTC
KAZIMI A JDirector · Chairman and CEO · 10% owner
Tax withholdingCommon Stock 37,205 $1.92 $71,433.60
Disclosure

SEC source: 0001209191-23-020349 · doc4.xml · nonDerivative · entry 1

KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,716,153

F1 · shares: This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares.

Read SEC document
March 18, 2023 Filed Mar 21, 2023 21:26 UTC
Herman James LVP and Chief Compliance Office
Tax withholdingCommon Stock 1,280 $1.92 $2,457.60
Disclosure

SEC source: 0001209191-23-020346 · doc4.xml · nonDerivative · entry 1

Herman James L · CIK 0001572342 · VP and Chief Compliance Office

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,441

F1 · shares: This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares.

Read SEC document
January 14, 2023 Filed Mar 21, 2023 21:28 UTC OtherCommon Stock 5,000 $2.75 $13,750.00
Disclosure

SEC source: 0001209191-23-020351 · doc4.xml · nonDerivative · entry 1

JACOBS JOEY A · CIK 0001243878 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 98,415

F1 · shares: Mr. Jacobs passed away January 14, 2023. All unvested equity awards forfeited upon death.

Read SEC document
December 21, 2022 Filed Dec 23, 2022 22:11 UTC
Jones JamesDirector
PurchaseCommon Stock 88 $2.22 $195.36
Disclosure

SEC source: 0001209191-22-062654 · doc4.xml · nonDerivative · entry 15

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,293

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 21, 2022 Filed Dec 23, 2022 22:10 UTC PurchaseCommon Stock 180 $2.22 $399.60
Disclosure

SEC source: 0001209191-22-062651 · doc4.xml · nonDerivative · entry 15

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,356

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 21, 2022 Filed Dec 23, 2022 22:07 UTC PurchaseCommon Stock 360 $2.22 $799.20
Disclosure

SEC source: 0001209191-22-062649 · doc4.xml · nonDerivative · entry 15

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 204,955

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 20, 2022 Filed Dec 23, 2022 22:13 UTC PurchaseCommon Stock 109 $2.31 $251.79
Disclosure

SEC source: 0001209191-22-062657 · doc4.xml · nonDerivative · entry 14

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,587

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 20, 2022 Filed Dec 23, 2022 22:11 UTC
Jones JamesDirector
PurchaseCommon Stock 121 $2.31 $279.51
Disclosure

SEC source: 0001209191-22-062654 · doc4.xml · nonDerivative · entry 14

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,205

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 20, 2022 Filed Dec 23, 2022 22:10 UTC PurchaseCommon Stock 200 $2.31 $462.00
Disclosure

SEC source: 0001209191-22-062651 · doc4.xml · nonDerivative · entry 14

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,176

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 20, 2022 Filed Dec 23, 2022 22:07 UTC PurchaseCommon Stock 370 $2.31 $854.70
Disclosure

SEC source: 0001209191-22-062649 · doc4.xml · nonDerivative · entry 14

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 204,595

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 19, 2022 Filed Dec 23, 2022 22:13 UTC PurchaseCommon Stock 30 $2.21 $66.30
Disclosure

SEC source: 0001209191-22-062657 · doc4.xml · nonDerivative · entry 13

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,478

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 19, 2022 Filed Dec 23, 2022 22:11 UTC
Jones JamesDirector
PurchaseCommon Stock 70 $2.21 $154.70
Disclosure

SEC source: 0001209191-22-062654 · doc4.xml · nonDerivative · entry 13

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,084

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 19, 2022 Filed Dec 23, 2022 22:10 UTC PurchaseCommon Stock 250 $2.21 $552.50
Disclosure

SEC source: 0001209191-22-062651 · doc4.xml · nonDerivative · entry 13

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,976

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 19, 2022 Filed Dec 23, 2022 22:07 UTC PurchaseCommon Stock 450 $2.21 $994.50
Disclosure

SEC source: 0001209191-22-062649 · doc4.xml · nonDerivative · entry 13

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 204,225

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 16, 2022 Filed Dec 23, 2022 22:13 UTC PurchaseCommon Stock 20 $2.22 $44.40
Disclosure

SEC source: 0001209191-22-062657 · doc4.xml · nonDerivative · entry 12

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,448

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 16, 2022 Filed Dec 23, 2022 22:11 UTC
Jones JamesDirector
PurchaseCommon Stock 40 $2.22 $88.80
Disclosure

SEC source: 0001209191-22-062654 · doc4.xml · nonDerivative · entry 12

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,014

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 16, 2022 Filed Dec 23, 2022 22:10 UTC PurchaseCommon Stock 100 $2.22 $222.00
Disclosure

SEC source: 0001209191-22-062651 · doc4.xml · nonDerivative · entry 12

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,726

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 16, 2022 Filed Dec 23, 2022 22:07 UTC PurchaseCommon Stock 246 $2.22 $546.12
Disclosure

SEC source: 0001209191-22-062649 · doc4.xml · nonDerivative · entry 12

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 203,775

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 15, 2022 Filed Dec 23, 2022 22:13 UTC PurchaseCommon Stock 20 $2.24 $44.80
Disclosure

SEC source: 0001209191-22-062657 · doc4.xml · nonDerivative · entry 11

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,428

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 15, 2022 Filed Dec 23, 2022 22:11 UTC
Jones JamesDirector
PurchaseCommon Stock 20 $2.24 $44.80
Disclosure

SEC source: 0001209191-22-062654 · doc4.xml · nonDerivative · entry 11

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,974

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 15, 2022 Filed Dec 23, 2022 22:10 UTC PurchaseCommon Stock 60 $2.24 $134.40
Disclosure

SEC source: 0001209191-22-062651 · doc4.xml · nonDerivative · entry 11

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,626

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 15, 2022 Filed Dec 23, 2022 22:07 UTC PurchaseCommon Stock 144 $2.24 $322.56
Disclosure

SEC source: 0001209191-22-062649 · doc4.xml · nonDerivative · entry 11

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 203,529

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 14, 2022 Filed Dec 23, 2022 22:13 UTC PurchaseCommon Stock 20 $2.21 $44.20
Disclosure

SEC source: 0001209191-22-062657 · doc4.xml · nonDerivative · entry 10

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,408

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 14, 2022 Filed Dec 23, 2022 22:11 UTC
Jones JamesDirector
PurchaseCommon Stock 40 $2.21 $88.40
Disclosure

SEC source: 0001209191-22-062654 · doc4.xml · nonDerivative · entry 10

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,954

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 14, 2022 Filed Dec 23, 2022 22:10 UTC PurchaseCommon Stock 120 $2.21 $265.20
Disclosure

SEC source: 0001209191-22-062651 · doc4.xml · nonDerivative · entry 10

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,566

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 14, 2022 Filed Dec 23, 2022 22:07 UTC PurchaseCommon Stock 320 $2.21 $707.20
Disclosure

SEC source: 0001209191-22-062649 · doc4.xml · nonDerivative · entry 10

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 203,385

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 13, 2022 Filed Dec 23, 2022 22:13 UTC PurchaseCommon Stock 20 $2.18 $43.60
Disclosure

SEC source: 0001209191-22-062657 · doc4.xml · nonDerivative · entry 9

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,388

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 13, 2022 Filed Dec 23, 2022 22:11 UTC
Jones JamesDirector
PurchaseCommon Stock 40 $2.18 $87.20
Disclosure

SEC source: 0001209191-22-062654 · doc4.xml · nonDerivative · entry 9

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,914

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 13, 2022 Filed Dec 23, 2022 22:10 UTC PurchaseCommon Stock 120 $2.18 $261.60
Disclosure

SEC source: 0001209191-22-062651 · doc4.xml · nonDerivative · entry 9

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,446

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 13, 2022 Filed Dec 23, 2022 22:07 UTC PurchaseCommon Stock 320 $2.18 $697.60
Disclosure

SEC source: 0001209191-22-062649 · doc4.xml · nonDerivative · entry 9

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 203,065

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 12, 2022 Filed Dec 23, 2022 22:13 UTC PurchaseCommon Stock 20 $2.14 $42.80
Disclosure

SEC source: 0001209191-22-062657 · doc4.xml · nonDerivative · entry 8

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,368

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 12, 2022 Filed Dec 23, 2022 22:11 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.14 $66.34
Disclosure

SEC source: 0001209191-22-062654 · doc4.xml · nonDerivative · entry 8

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,874

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 12, 2022 Filed Dec 23, 2022 22:10 UTC PurchaseCommon Stock 65 $2.14 $139.10
Disclosure

SEC source: 0001209191-22-062651 · doc4.xml · nonDerivative · entry 8

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,326

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 12, 2022 Filed Dec 23, 2022 22:07 UTC PurchaseCommon Stock 105 $2.14 $224.70
Disclosure

SEC source: 0001209191-22-062649 · doc4.xml · nonDerivative · entry 8

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 202,745

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 09, 2022 Filed Dec 23, 2022 22:13 UTC PurchaseCommon Stock 20 $2.15 $43.00
Disclosure

SEC source: 0001209191-22-062657 · doc4.xml · nonDerivative · entry 7

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,348

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 09, 2022 Filed Dec 23, 2022 22:11 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.15 $66.65
Disclosure

SEC source: 0001209191-22-062654 · doc4.xml · nonDerivative · entry 7

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,843

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 09, 2022 Filed Dec 23, 2022 22:10 UTC PurchaseCommon Stock 65 $2.15 $139.75
Disclosure

SEC source: 0001209191-22-062651 · doc4.xml · nonDerivative · entry 7

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,261

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 09, 2022 Filed Dec 23, 2022 22:07 UTC PurchaseCommon Stock 105 $2.15 $225.75
Disclosure

SEC source: 0001209191-22-062649 · doc4.xml · nonDerivative · entry 7

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 202,640

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 08, 2022 Filed Dec 23, 2022 22:13 UTC PurchaseCommon Stock 20 $2.19 $43.80
Disclosure

SEC source: 0001209191-22-062657 · doc4.xml · nonDerivative · entry 6

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,328

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 08, 2022 Filed Dec 23, 2022 22:11 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.19 $67.89
Disclosure

SEC source: 0001209191-22-062654 · doc4.xml · nonDerivative · entry 6

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,812

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 08, 2022 Filed Dec 23, 2022 22:10 UTC PurchaseCommon Stock 65 $2.19 $142.35
Disclosure

SEC source: 0001209191-22-062651 · doc4.xml · nonDerivative · entry 6

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,196

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 08, 2022 Filed Dec 23, 2022 22:07 UTC PurchaseCommon Stock 105 $2.19 $229.95
Disclosure

SEC source: 0001209191-22-062649 · doc4.xml · nonDerivative · entry 6

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 202,535

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 07, 2022 Filed Dec 23, 2022 22:13 UTC PurchaseCommon Stock 20 $2.18 $43.60
Disclosure

SEC source: 0001209191-22-062657 · doc4.xml · nonDerivative · entry 5

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,308

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 07, 2022 Filed Dec 23, 2022 22:11 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.18 $67.58
Disclosure

SEC source: 0001209191-22-062654 · doc4.xml · nonDerivative · entry 5

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,781

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 07, 2022 Filed Dec 23, 2022 22:10 UTC PurchaseCommon Stock 65 $2.18 $141.70
Disclosure

SEC source: 0001209191-22-062651 · doc4.xml · nonDerivative · entry 5

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,131

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 07, 2022 Filed Dec 23, 2022 22:07 UTC PurchaseCommon Stock 105 $2.18 $228.90
Disclosure

SEC source: 0001209191-22-062649 · doc4.xml · nonDerivative · entry 5

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 202,430

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 06, 2022 Filed Dec 23, 2022 22:13 UTC PurchaseCommon Stock 20 $2.19 $43.80
Disclosure

SEC source: 0001209191-22-062657 · doc4.xml · nonDerivative · entry 4

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,288

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 06, 2022 Filed Dec 23, 2022 22:11 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.19 $67.89
Disclosure

SEC source: 0001209191-22-062654 · doc4.xml · nonDerivative · entry 4

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,750

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 06, 2022 Filed Dec 23, 2022 22:10 UTC PurchaseCommon Stock 65 $2.19 $142.35
Disclosure

SEC source: 0001209191-22-062651 · doc4.xml · nonDerivative · entry 4

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,066

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.